Abstract |
Chemotherapeutic nanomedicines can exploit the neighboring effect to increase tumor penetration. However, the neighboring effect is limited, likely by the consumption of chemotherapeutic agents and resistance of internal hypoxic tumor cells. Here, we first propose and demonstrate that apoptotic bodies (ApoBDs) could carry the remaining drugs to neighboring tumor cells after apoptosis. To enhance the ApoBD-based neighboring effect, we fabricated disulfide-linked prodrug nanoparticles consisting of camptothecin ( CPT) and hypoxia-activated prodrug PR104A. CPT kills external normoxic tumor cells to produce ApoBDs, while PR104A remains inactive. The remaining drugs could be effectively delivered into internal tumor cells via ApoBDs. Although CPT exhibits low toxicity to internal hypoxic tumor cells, PR104A could be activated to exert strong cytotoxicity, which further facilitates deep penetration of the remaining drugs. Such a synergic approach could overcome the limitations of the neighboring effect to penetrate deep into solid tumors for whole tumor destruction.
|
Authors | Dongyang Zhao, Wenhui Tao, Songhao Li, Yao Chen, Yinghua Sun, Zhonggui He, Bingjun Sun, Jin Sun |
Journal | Science advances
(Sci Adv)
Vol. 7
Issue 16
(04 2021)
ISSN: 2375-2548 [Electronic] United States |
PMID | 33863733
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). |
Chemical References |
- Antineoplastic Agents
- Prodrugs
- Camptothecin
|
Topics |
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Camptothecin
(pharmacology, therapeutic use)
- Cell Line, Tumor
- Drug Delivery Systems
- Extracellular Vesicles
- Humans
- Nanoparticles
- Neoplasms
(drug therapy)
- Prodrugs
(pharmacology)
|